<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://www.jco.org/">
<title>J. Clin. Oncol.: Most-Cited Full-Text Articles</title>
<link>http://www.jco.org/</link>
<description>Most-cited rankings are recalculated at the beginning of the month and are based on citations to articles on this journal site from articles in other HighWire-hosted journals.</description>
<prism:coverDisplayDate>2010-02-06</prism:coverDisplayDate>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/17/4/1244?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/21/12/2237?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/18/16/2938?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/16/8/2825?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/17/9/2639?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/15/6/2403?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/17/12/3835?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/20/3/719?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/11/3/570?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/22/1/23?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/22/2/229?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/19/16/3635?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/22/7/1201?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/22/5/785?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/18/10/2095?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/14/3/737?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/22/5/777?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/8/7/1277?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/21/1/60?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/21/8/1431?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/16/8/2672?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/21/23/4342?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/11/8/1466?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/21/6/976?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/21/14/2636?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/22/9/1589?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/14/1/7?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/19/16/3622?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/19/13/3210?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/7/11/1748?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/17/5/1474?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/19/13/3267?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/18/1/136?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/19/18/3808?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/16/8/2659?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/20/9/2240?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/23/10/2346?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/22/11/2184?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/17/11/3461?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/21/14/2787?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/20/21/4292?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/19/11/2865?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/15/2/433?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/22/16/3238?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/8/5/813?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/23/5/1011?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/23/25/5892?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/18/12/2354?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/10/6/896?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jco.org/cgi/content/short/15/2/594?rss=1&amp;ssource=mfc" />
 </rdf:Seq>
</items>
</channel>

<item rdf:about="http://www.jco.org/cgi/content/short/17/4/1244?rss=1&amp;ssource=mfc">
<title><![CDATA[Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas]]></title>
<link>http://www.jco.org/cgi/content/short/17/4/1244?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Bruce D. Cheson, Sandra J. Horning, Bertr Coiffier, Margaret A. Shipp, Richard I. Fisher, Joseph M. Connors, T. Andrew Lister, Julie Vose, Antonio Grillo-Lopez, Anton Hagenbeek, Fernando Cabanillas, Donald Klippensten, Wolfgang Hiddemann, Ronald Castellino, Nancy L. Harris, James O. Armitage, William Carter, Richard Hoppe, George P. Canellos<br />Apr  1, 1999; 17:1244-1244<br />Hematologic Malignancies]]></description>
<dc:creator>Bruce D. Cheson, Sandra J. Horning, Bertr Coiffier, Margaret A. Shipp, Richard I. Fisher, Joseph M. Connors, T. Andrew Lister, Julie Vose, Antonio Grillo-Lopez, Anton Hagenbeek, Fernando Cabanillas, Donald Klippensten, Wolfgang Hiddemann, Ronald Castellino, Nancy L. Harris, James O. Armitage, William Carter, Richard Hoppe, George P. Canellos</dc:creator>
<dc:date>1999-04-01</dc:date>
<dc:title><![CDATA[Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/21/12/2237?rss=1&amp;ssource=mfc">
<title><![CDATA[Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer]]></title>
<link>http://www.jco.org/cgi/content/short/21/12/2237?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Masahiro Fukuoka, Seiji Yano, Giuseppe Giaccone, Tomohide Tamura, Kazuhiko Nakagawa, Jean-Yves Douillard, Yutaka Nishiwaki, Johan Vansteenkiste, Shinzoh Kudoh, Danny Rischin, Richard Eek, Takeshi Horai, Kazumasa Noda, Ichiro Takata, Egbert Smit, Steven Averbuch, Angela Macleod, Andrea Feyereislova, Rui-Ping Dong, Jose Baselga<br />Jun 15, 2003; 21:2237-2246<br />Lung Cancer]]></description>
<dc:creator>Masahiro Fukuoka, Seiji Yano, Giuseppe Giaccone, Tomohide Tamura, Kazuhiko Nakagawa, Jean-Yves Douillard, Yutaka Nishiwaki, Johan Vansteenkiste, Shinzoh Kudoh, Danny Rischin, Richard Eek, Takeshi Horai, Kazumasa Noda, Ichiro Takata, Egbert Smit, Steven Averbuch, Angela Macleod, Andrea Feyereislova, Rui-Ping Dong, Jose Baselga</dc:creator>
<dc:date>2003-06-15</dc:date>
<dc:title><![CDATA[Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/18/16/2938?rss=1&amp;ssource=mfc">
<title><![CDATA[Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer]]></title>
<link>http://www.jco.org/cgi/content/short/18/16/2938?rss=1&amp;ssource=mfc</link>
<description><![CDATA[A. de Gramont, A. Figer, M. Seymour, M. Homerin, A. Hmissi, J. Cassidy, C. Boni, H. Cortes-Funes, A. Cervantes, G. Freyer, D. Papamichael, N. Le Bail, C. Louvet, D. Hendler, F. de Braud, C. Wilson, F. Morvan, A. Bonetti<br />Aug 16, 2000; 18:2938-2947<br />Gastrointestinal Cancer]]></description>
<dc:creator>A. de Gramont, A. Figer, M. Seymour, M. Homerin, A. Hmissi, J. Cassidy, C. Boni, H. Cortes-Funes, A. Cervantes, G. Freyer, D. Papamichael, N. Le Bail, C. Louvet, D. Hendler, F. de Braud, C. Wilson, F. Morvan, A. Bonetti</dc:creator>
<dc:date>2000-08-16</dc:date>
<dc:title><![CDATA[Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/16/8/2825?rss=1&amp;ssource=mfc">
<title><![CDATA[Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program]]></title>
<link>http://www.jco.org/cgi/content/short/16/8/2825?rss=1&amp;ssource=mfc</link>
<description><![CDATA[P McLaughlin, AJ Grillo-Lopez, BK Link, R Levy, MS Czuczman, ME Williams, MR Heyman, I Bence-Bruckler, CA White, F Cabanillas, V Jain, AD Ho, J Lister, K Wey, D Shen, BK Dallaire<br />Aug  1, 1998; 16:2825-2833<br />ARTICLES]]></description>
<dc:creator>P McLaughlin, AJ Grillo-Lopez, BK Link, R Levy, MS Czuczman, ME Williams, MR Heyman, I Bence-Bruckler, CA White, F Cabanillas, V Jain, AD Ho, J Lister, K Wey, D Shen, BK Dallaire</dc:creator>
<dc:date>1998-08-01</dc:date>
<dc:title><![CDATA[Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/17/9/2639?rss=1&amp;ssource=mfc">
<title><![CDATA[Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease]]></title>
<link>http://www.jco.org/cgi/content/short/17/9/2639?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Melody A. Cobleigh, Charles L. Vogel, Debu Tripathy, Nicholas J. Robert, Susy Scholl, Louis Fehrenbacher, Janet M. Wolter, Virginia Paton, Steven Shak, Gracie Lieberman, Dennis J. Slamon<br />Sep  1, 1999; 17:2639-2639<br />Breast Cancer]]></description>
<dc:creator>Melody A. Cobleigh, Charles L. Vogel, Debu Tripathy, Nicholas J. Robert, Susy Scholl, Louis Fehrenbacher, Janet M. Wolter, Virginia Paton, Steven Shak, Gracie Lieberman, Dennis J. Slamon</dc:creator>
<dc:date>1999-09-01</dc:date>
<dc:title><![CDATA[Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/15/6/2403?rss=1&amp;ssource=mfc">
<title><![CDATA[Improvements in survival and clinical benefit with gemcitabine as first- line therapy for patients with advanced pancreas cancer: a randomized trial]]></title>
<link>http://www.jco.org/cgi/content/short/15/6/2403?rss=1&amp;ssource=mfc</link>
<description><![CDATA[HA Burris 3rd, MJ Moore, J Andersen, MR Green, ML Rothenberg, MR Modiano, MC Cripps, RK Portenoy, AM Storniolo, P Tarassoff, R Nelson, FA Dorr, CD Stephens, DD Von Hoff<br />Jun  1, 1997; 15:2403-2413<br />ARTICLES]]></description>
<dc:creator>HA Burris 3rd, MJ Moore, J Andersen, MR Green, ML Rothenberg, MR Modiano, MC Cripps, RK Portenoy, AM Storniolo, P Tarassoff, R Nelson, FA Dorr, CD Stephens, DD Von Hoff</dc:creator>
<dc:date>1997-06-01</dc:date>
<dc:title><![CDATA[Improvements in survival and clinical benefit with gemcitabine as first- line therapy for patients with advanced pancreas cancer: a randomized trial]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/17/12/3835?rss=1&amp;ssource=mfc">
<title><![CDATA[World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee MeetingAirlie House, Virginia, November 1997]]></title>
<link>http://www.jco.org/cgi/content/short/17/12/3835?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Nancy Lee Harris, Elaine S. Jaffe, Jacques Diebold, Georges Flandrin, H. Konrad Muller-Hermelink, James Vardiman, T. Andrew Lister, Clara D. Bloomfield<br />Dec  1, 1999; 17:3835-3849<br />SPECIAL ARTICLES]]></description>
<dc:creator>Nancy Lee Harris, Elaine S. Jaffe, Jacques Diebold, Georges Flandrin, H. Konrad Muller-Hermelink, James Vardiman, T. Andrew Lister, Clara D. Bloomfield</dc:creator>
<dc:date>1999-12-01</dc:date>
<dc:title><![CDATA[World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee MeetingAirlie House, Virginia, November 1997]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/20/3/719?rss=1&amp;ssource=mfc">
<title><![CDATA[Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer]]></title>
<link>http://www.jco.org/cgi/content/short/20/3/719?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Charles L. Vogel, Melody A. Cobleigh, Debu Tripathy, John C. Gutheil, Lyndsay N. Harris, Louis Fehrenbacher, Dennis J. Slamon, Maureen Murphy, William F. Novotny, Michael Burchmore, Steven Shak, Stanford J. Stewart, Michael Press<br />Feb  1, 2002; 20:719-726<br />Breast Cancer]]></description>
<dc:creator>Charles L. Vogel, Melody A. Cobleigh, Debu Tripathy, John C. Gutheil, Lyndsay N. Harris, Louis Fehrenbacher, Dennis J. Slamon, Maureen Murphy, William F. Novotny, Michael Burchmore, Steven Shak, Stanford J. Stewart, Michael Press</dc:creator>
<dc:date>2002-02-01</dc:date>
<dc:identifier>10.1200/JCO.20.3.719</dc:identifier>
<dc:title><![CDATA[Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/11/3/570?rss=1&amp;ssource=mfc">
<title><![CDATA[The Functional Assessment of Cancer Therapy scale: development and validation of the general measure]]></title>
<link>http://www.jco.org/cgi/content/short/11/3/570?rss=1&amp;ssource=mfc</link>
<description><![CDATA[DF Cella, DS Tulsky, G Gray, B Sarafian, E Linn, A Bonomi, M Silberman, SB Yellen, P Winicour, J Brannon<br />Mar  1, 1993; 11:570-579<br />ARTICLES]]></description>
<dc:creator>DF Cella, DS Tulsky, G Gray, B Sarafian, E Linn, A Bonomi, M Silberman, SB Yellen, P Winicour, J Brannon</dc:creator>
<dc:date>1993-03-01</dc:date>
<dc:title><![CDATA[The Functional Assessment of Cancer Therapy scale: development and validation of the general measure]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/22/1/23?rss=1&amp;ssource=mfc">
<title><![CDATA[A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer]]></title>
<link>http://www.jco.org/cgi/content/short/22/1/23?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Richard M. Goldberg, Daniel J. Sargent, Roscoe F. Morton, Charles S. Fuchs, Ramesh K. Ramanathan, Stephen K. Williamson, Brian P. Findlay, Henry C. Pitot, Steven R. Alberts<br />Jan  1, 2004; 22:23-30<br />Gastrointestinal Cancer]]></description>
<dc:creator>Richard M. Goldberg, Daniel J. Sargent, Roscoe F. Morton, Charles S. Fuchs, Ramesh K. Ramanathan, Stephen K. Williamson, Brian P. Findlay, Henry C. Pitot, Steven R. Alberts</dc:creator>
<dc:date>2004-01-01</dc:date>
<dc:title><![CDATA[A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/22/2/229?rss=1&amp;ssource=mfc">
<title><![CDATA[FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study]]></title>
<link>http://www.jco.org/cgi/content/short/22/2/229?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Christophe Tournigand, Thierry Andre, Emmanuel Achille, Gerard Lledo, Michel Flesh, Dominique Mery-Mignard, Emmanuel Quinaux, Corinne Couteau, Marc Buyse, Gerard Ganem, Bruno Landi, Philippe Colin, Christophe Louvet, Aimery de Gramont<br />Jan 15, 2004; 22:229-237<br />Gastrointestinal Cancer]]></description>
<dc:creator>Christophe Tournigand, Thierry Andre, Emmanuel Achille, Gerard Lledo, Michel Flesh, Dominique Mery-Mignard, Emmanuel Quinaux, Corinne Couteau, Marc Buyse, Gerard Ganem, Bruno Landi, Philippe Colin, Christophe Louvet, Aimery de Gramont</dc:creator>
<dc:date>2004-01-15</dc:date>
<dc:title><![CDATA[FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/19/16/3635?rss=1&amp;ssource=mfc">
<title><![CDATA[Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma]]></title>
<link>http://www.jco.org/cgi/content/short/19/16/3635?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Charles M. Balch, Antonio C. Buzaid, Seng-Jaw Soong, Michael B. Atkins, Natale Cascinelli, Daniel G. Coit, Irvin D. Fleming, Jeffrey E. Gershenwald, Alan Houghton Jr, John M. Kirkwood, Kelly M. McMasters, Martin F. Mihm, Donald L. Morton, Douglas S. Reintgen, Merrick I. Ross, Arthur Sober, John A. Thompson, John F. Thompson<br />Aug 15, 2001; 19:3635-3648<br />Melanoma]]></description>
<dc:creator>Charles M. Balch, Antonio C. Buzaid, Seng-Jaw Soong, Michael B. Atkins, Natale Cascinelli, Daniel G. Coit, Irvin D. Fleming, Jeffrey E. Gershenwald, Alan Houghton Jr, John M. Kirkwood, Kelly M. McMasters, Martin F. Mihm, Donald L. Morton, Douglas S. Reintgen, Merrick I. Ross, Arthur Sober, John A. Thompson, John F. Thompson</dc:creator>
<dc:date>2001-08-15</dc:date>
<dc:title><![CDATA[Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/22/7/1201?rss=1&amp;ssource=mfc">
<title><![CDATA[Phase II Trial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal Growth Factor Receptor]]></title>
<link>http://www.jco.org/cgi/content/short/22/7/1201?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Leonard B. Saltz, Neal J. Meropol, Patrick J. Loehrer Sr, Michael N. Needle, Justin Kopit, Robert J. Mayer<br />Apr  1, 2004; 22:1201-1208<br />Gastrointestinal Cancer]]></description>
<dc:creator>Leonard B. Saltz, Neal J. Meropol, Patrick J. Loehrer Sr, Michael N. Needle, Justin Kopit, Robert J. Mayer</dc:creator>
<dc:date>2004-04-01</dc:date>
<dc:title><![CDATA[Phase II Trial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal Growth Factor Receptor]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/22/5/785?rss=1&amp;ssource=mfc">
<title><![CDATA[Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non-Small-Cell Lung Cancer: A Phase III Trial--INTACT 2]]></title>
<link>http://www.jco.org/cgi/content/short/22/5/785?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Roy S. Herbst, Giuseppe Giaccone, Joan H. Schiller, Ronald B. Natale, Vincent Miller, Christian Manegold, Giorgio Scagliotti, Rafael Rosell, Ira Oliff, James A. Reeves, Michael K. Wolf, Annetta D. Krebs, Steven D. Averbuch, Judith S. Ochs, John Grous, Abderrahim Fandi, David H. Johnson<br />Mar  1, 2004; 22:785-794<br />Lung Cancer]]></description>
<dc:creator>Roy S. Herbst, Giuseppe Giaccone, Joan H. Schiller, Ronald B. Natale, Vincent Miller, Christian Manegold, Giorgio Scagliotti, Rafael Rosell, Ira Oliff, James A. Reeves, Michael K. Wolf, Annetta D. Krebs, Steven D. Averbuch, Judith S. Ochs, John Grous, Abderrahim Fandi, David H. Johnson</dc:creator>
<dc:date>2004-03-01</dc:date>
<dc:title><![CDATA[Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non-Small-Cell Lung Cancer: A Phase III Trial--INTACT 2]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/18/10/2095?rss=1&amp;ssource=mfc">
<title><![CDATA[Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non-Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy]]></title>
<link>http://www.jco.org/cgi/content/short/18/10/2095?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Frances A. Shepherd, Janet Dancey, Rodryg Ramlau, Karin Mattson, Richard Gralla, Mark O''Rourke, Nathan Levitan, Laurent Gressot, Mark Vincent, Ronald Burkes, Susan Coughlin, Yong Kim, Jocelyne Berille<br />May 10, 2000; 18:2095-2103<br />Lung Cancer]]></description>
<dc:creator>Frances A. Shepherd, Janet Dancey, Rodryg Ramlau, Karin Mattson, Richard Gralla, Mark O''Rourke, Nathan Levitan, Laurent Gressot, Mark Vincent, Ronald Burkes, Susan Coughlin, Yong Kim, Jocelyne Berille</dc:creator>
<dc:date>2000-05-10</dc:date>
<dc:title><![CDATA[Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non-Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/14/3/737?rss=1&amp;ssource=mfc">
<title><![CDATA[Phase II study of weekly intravenous recombinant humanized anti- p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer]]></title>
<link>http://www.jco.org/cgi/content/short/14/3/737?rss=1&amp;ssource=mfc</link>
<description><![CDATA[J Baselga, D Tripathy, J Mendelsohn, S Baughman, CC Benz, L Dantis, NT Sklarin, AD Seidman, CA Hudis, J Moore, PP Rosen, T Twaddell, IC Henderson, L Norton<br />Mar  1, 1996; 14:737-744<br />ARTICLES]]></description>
<dc:creator>J Baselga, D Tripathy, J Mendelsohn, S Baughman, CC Benz, L Dantis, NT Sklarin, AD Seidman, CA Hudis, J Moore, PP Rosen, T Twaddell, IC Henderson, L Norton</dc:creator>
<dc:date>1996-03-01</dc:date>
<dc:title><![CDATA[Phase II study of weekly intravenous recombinant humanized anti- p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/22/5/777?rss=1&amp;ssource=mfc">
<title><![CDATA[Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non-Small-Cell Lung Cancer: A Phase III Trial--INTACT 1]]></title>
<link>http://www.jco.org/cgi/content/short/22/5/777?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Giuseppe Giaccone, Roy S. Herbst, Christian Manegold, Giorgio Scagliotti, Rafael Rosell, Vincent Miller, Ronald B. Natale, Joan H. Schiller, Joachim von Pawel, Anna Pluzanska, Ulrich Gatzemeier, John Grous, Judith S. Ochs, Steven D. Averbuch, Michael K. Wolf, Pamela Rennie, Abderrahim Fandi, David H. Johnson<br />Mar  1, 2004; 22:777-784<br />Lung Cancer]]></description>
<dc:creator>Giuseppe Giaccone, Roy S. Herbst, Christian Manegold, Giorgio Scagliotti, Rafael Rosell, Vincent Miller, Ronald B. Natale, Joan H. Schiller, Joachim von Pawel, Anna Pluzanska, Ulrich Gatzemeier, John Grous, Judith S. Ochs, Steven D. Averbuch, Michael K. Wolf, Pamela Rennie, Abderrahim Fandi, David H. Johnson</dc:creator>
<dc:date>2004-03-01</dc:date>
<dc:title><![CDATA[Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non-Small-Cell Lung Cancer: A Phase III Trial--INTACT 1]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/8/7/1277?rss=1&amp;ssource=mfc">
<title><![CDATA[Response criteria for phase II studies of supratentorial malignant glioma]]></title>
<link>http://www.jco.org/cgi/content/short/8/7/1277?rss=1&amp;ssource=mfc</link>
<description><![CDATA[DR Macdonald, TL Cascino, SC Schold Jr, JG Cairncross<br />Jul  1, 1990; 8:1277-1280<br />ARTICLES]]></description>
<dc:creator>DR Macdonald, TL Cascino, SC Schold Jr, JG Cairncross</dc:creator>
<dc:date>1990-07-01</dc:date>
<dc:title><![CDATA[Response criteria for phase II studies of supratentorial malignant glioma]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/21/1/60?rss=1&amp;ssource=mfc">
<title><![CDATA[Phase II, Randomized Trial Comparing Bevacizumab Plus Fluorouracil (FU)/Leucovorin (LV) With FU/LV Alone in Patients With Metastatic Colorectal Cancer]]></title>
<link>http://www.jco.org/cgi/content/short/21/1/60?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Fairooz Kabbinavar, Herbert I. Hurwitz, Louis Fehrenbacher, Neal J. Meropol, William F. Novotny, Grazyna Lieberman, Susan Griffing, Emily Bergsland<br />Jan  1, 2003; 21:60-65<br />Gastrointestinal Cancer]]></description>
<dc:creator>Fairooz Kabbinavar, Herbert I. Hurwitz, Louis Fehrenbacher, Neal J. Meropol, William F. Novotny, Grazyna Lieberman, Susan Griffing, Emily Bergsland</dc:creator>
<dc:date>2003-01-01</dc:date>
<dc:title><![CDATA[Phase II, Randomized Trial Comparing Bevacizumab Plus Fluorouracil (FU)/Leucovorin (LV) With FU/LV Alone in Patients With Metastatic Colorectal Cancer]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/21/8/1431?rss=1&amp;ssource=mfc">
<title><![CDATA[Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741]]></title>
<link>http://www.jco.org/cgi/content/short/21/8/1431?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Marc L. Citron, Donald A. Berry, Constance Cirrincione, Clifford Hudis, Eric P. Winer, William J. Gradishar, Nancy E. Davidson, Silvana Martino, Robert Livingston, James N. Ingle, Edith A. Perez, John Carpenter, David Hurd, James F. Holland, Barbara L. Smith, Carolyn I. Sartor, Eleanor H. Leung, Jeffrey Abrams, Richard L. Schilsky, Hyman B. Muss, Larry Norton<br />Apr 15, 2003; 21:1431-1439<br />Breast Cancer]]></description>
<dc:creator>Marc L. Citron, Donald A. Berry, Constance Cirrincione, Clifford Hudis, Eric P. Winer, William J. Gradishar, Nancy E. Davidson, Silvana Martino, Robert Livingston, James N. Ingle, Edith A. Perez, John Carpenter, David Hurd, James F. Holland, Barbara L. Smith, Carolyn I. Sartor, Eleanor H. Leung, Jeffrey Abrams, Richard L. Schilsky, Hyman B. Muss, Larry Norton</dc:creator>
<dc:date>2003-04-15</dc:date>
<dc:title><![CDATA[Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/16/8/2672?rss=1&amp;ssource=mfc">
<title><![CDATA[Effect of preoperative chemotherapy on the outcome of women with operable breast cancer]]></title>
<link>http://www.jco.org/cgi/content/short/16/8/2672?rss=1&amp;ssource=mfc</link>
<description><![CDATA[B Fisher, J Bryant, N Wolmark, E Mamounas, A Brown, ER Fisher, DL Wickerham, M Begovic, A DeCillis, A Robidoux, RG Margolese, AB Cruz Jr, JL Hoehn, AW Lees, NV Dimitrov, HD Bear<br />Aug  1, 1998; 16:2672-2685<br />ARTICLES]]></description>
<dc:creator>B Fisher, J Bryant, N Wolmark, E Mamounas, A Brown, ER Fisher, DL Wickerham, M Begovic, A DeCillis, A Robidoux, RG Margolese, AB Cruz Jr, JL Hoehn, AW Lees, NV Dimitrov, HD Bear</dc:creator>
<dc:date>1998-08-01</dc:date>
<dc:title><![CDATA[Effect of preoperative chemotherapy on the outcome of women with operable breast cancer]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/21/23/4342?rss=1&amp;ssource=mfc">
<title><![CDATA[Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor]]></title>
<link>http://www.jco.org/cgi/content/short/21/23/4342?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Michael C. Heinrich, Christopher L. Corless, George D. Demetri, Charles D. Blanke, Margaret von Mehren, Heikki Joensuu, Laura S. McGreevey, Chang-Jie Chen, Annick D. Van den Abbeele, Brian J. Druker, Beate Kiese, Burton Eisenberg, Peter J. Roberts, Samuel Singer, Christopher D.M. Fletcher, Sandra Silberman, Sasa Dimitrijevic, Jonathan A. Fletcher<br />Dec  1, 2003; 21:4342-4349<br />Gastrointestinal Cancer]]></description>
<dc:creator>Michael C. Heinrich, Christopher L. Corless, George D. Demetri, Charles D. Blanke, Margaret von Mehren, Heikki Joensuu, Laura S. McGreevey, Chang-Jie Chen, Annick D. Van den Abbeele, Brian J. Druker, Beate Kiese, Burton Eisenberg, Peter J. Roberts, Samuel Singer, Christopher D.M. Fletcher, Sandra Silberman, Sasa Dimitrijevic, Jonathan A. Fletcher</dc:creator>
<dc:date>2003-12-01</dc:date>
<dc:title><![CDATA[Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/11/8/1466?rss=1&amp;ssource=mfc">
<title><![CDATA[Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment]]></title>
<link>http://www.jco.org/cgi/content/short/11/8/1466?rss=1&amp;ssource=mfc</link>
<description><![CDATA[GM Brodeur, J Pritchard, F Berthold, NL Carlsen, V Castel, RP Castelberry, B De Bernardi, AE Evans, M Favrot, F Hedborg<br />Aug  1, 1993; 11:1466-1477<br />ARTICLES]]></description>
<dc:creator>GM Brodeur, J Pritchard, F Berthold, NL Carlsen, V Castel, RP Castelberry, B De Bernardi, AE Evans, M Favrot, F Hedborg</dc:creator>
<dc:date>1993-08-01</dc:date>
<dc:title><![CDATA[Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/21/6/976?rss=1&amp;ssource=mfc">
<title><![CDATA[Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer]]></title>
<link>http://www.jco.org/cgi/content/short/21/6/976?rss=1&amp;ssource=mfc</link>
<description><![CDATA[I. Craig Henderson, Donald A. Berry, George D. Demetri, Constance T. Cirrincione, Lori J. Goldstein, Silvana Martino, James N. Ingle, M. Robert Cooper, Daniel F. Hayes, Katherine H. Tkaczuk, Gini Fleming, James F. Holland, David B. Duggan, John T. Carpenter, Emil Frei III, Richard L. Schilsky, William C. Wood, Hyman B. Muss, Larry Norton<br />Mar 15, 2003; 21:976-983<br />Breast Cancer]]></description>
<dc:creator>I. Craig Henderson, Donald A. Berry, George D. Demetri, Constance T. Cirrincione, Lori J. Goldstein, Silvana Martino, James N. Ingle, M. Robert Cooper, Daniel F. Hayes, Katherine H. Tkaczuk, Gini Fleming, James F. Holland, David B. Duggan, John T. Carpenter, Emil Frei III, Richard L. Schilsky, William C. Wood, Hyman B. Muss, Larry Norton</dc:creator>
<dc:date>2003-03-15</dc:date>
<dc:title><![CDATA[Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/21/14/2636?rss=1&amp;ssource=mfc">
<title><![CDATA[Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma]]></title>
<link>http://www.jco.org/cgi/content/short/21/14/2636?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Nicholas J. Vogelzang, James J. Rusthoven, James Symanowski, Claude Denham, E. Kaukel, Pierre Ruffie, Ulrich Gatzemeier, Michael Boyer, Salih Emri, Christian Manegold, Clet Niyikiza, Paolo Paoletti<br />Jul 15, 2003; 21:2636-2644<br />Lung Cancer]]></description>
<dc:creator>Nicholas J. Vogelzang, James J. Rusthoven, James Symanowski, Claude Denham, E. Kaukel, Pierre Ruffie, Ulrich Gatzemeier, Michael Boyer, Salih Emri, Christian Manegold, Clet Niyikiza, Paolo Paoletti</dc:creator>
<dc:date>2003-07-15</dc:date>
<dc:title><![CDATA[Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/22/9/1589?rss=1&amp;ssource=mfc">
<title><![CDATA[Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy]]></title>
<link>http://www.jco.org/cgi/content/short/22/9/1589?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Nasser Hanna, Frances A. Shepherd, Frank V. Fossella, Jose R. Pereira, Filippo De Marinis, Joachim von Pawel, Ulrich Gatzemeier, Thomas Chang Yao Tsao, Miklos Pless, Thomas Muller, Hong-Liang Lim, Christopher Desch, Klara Szondy, Radj Gervais,   Shaharyar, Christian Manegold, Sofia Paul, Paolo Paoletti, Lawrence Einhorn, Paul A. Bunn Jr.<br />May  1, 2004; 22:1589-1597<br />Lung Cancer]]></description>
<dc:creator>Nasser Hanna, Frances A. Shepherd, Frank V. Fossella, Jose R. Pereira, Filippo De Marinis, Joachim von Pawel, Ulrich Gatzemeier, Thomas Chang Yao Tsao, Miklos Pless, Thomas Muller, Hong-Liang Lim, Christopher Desch, Klara Szondy, Radj Gervais,   Shaharyar, Christian Manegold, Sofia Paul, Paolo Paoletti, Lawrence Einhorn, Paul A. Bunn Jr.</dc:creator>
<dc:date>2004-05-01</dc:date>
<dc:title><![CDATA[Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/14/1/7?rss=1&amp;ssource=mfc">
<title><![CDATA[Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684]]></title>
<link>http://www.jco.org/cgi/content/short/14/1/7?rss=1&amp;ssource=mfc</link>
<description><![CDATA[JM Kirkwood, MH Strawderman, MS Ernstoff, TJ Smith, EC Borden, RH Blum<br />Jan  1, 1996; 14:7-17<br />ARTICLES]]></description>
<dc:creator>JM Kirkwood, MH Strawderman, MS Ernstoff, TJ Smith, EC Borden, RH Blum</dc:creator>
<dc:date>1996-01-01</dc:date>
<dc:title><![CDATA[Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/19/16/3622?rss=1&amp;ssource=mfc">
<title><![CDATA[Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System]]></title>
<link>http://www.jco.org/cgi/content/short/19/16/3622?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Charles M. Balch, Seng-Jaw Soong, Jeffrey E. Gershenwald, John F. Thompson, Douglas S. Reintgen, Natale Cascinelli, Marshall Urist, Kelly M. McMasters, Merrick I. Ross, John M. Kirkwood, Michael B. Atkins, John A. Thompson, Daniel G. Coit, David Byrd, Renee Desmond, Yuting Zhang, Ping-Yu Liu, Gary H. Lyman, Aberto Morabito<br />Aug 15, 2001; 19:3622-3634<br />Melanoma]]></description>
<dc:creator>Charles M. Balch, Seng-Jaw Soong, Jeffrey E. Gershenwald, John F. Thompson, Douglas S. Reintgen, Natale Cascinelli, Marshall Urist, Kelly M. McMasters, Merrick I. Ross, John M. Kirkwood, Michael B. Atkins, John A. Thompson, Daniel G. Coit, David Byrd, Renee Desmond, Yuting Zhang, Ping-Yu Liu, Gary H. Lyman, Aberto Morabito</dc:creator>
<dc:date>2001-08-15</dc:date>
<dc:title><![CDATA[Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/19/13/3210?rss=1&amp;ssource=mfc">
<title><![CDATA[Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non-Small-Cell Lung Cancer: A Southwest Oncology Group Trial]]></title>
<link>http://www.jco.org/cgi/content/short/19/13/3210?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Karen Kelly, John Crowley, Paul A. Bunn Jr, Cary A. Presant, Patra K. Grevstad, Carol M. Moinpour, Scott D. Ramsey, Antoinette J. Wozniak, Geoffrey R. Weiss, Dennis F. Moore, Valerie K. Israel, Robert B. Livingston, David R. Gandara<br />Jul  1, 2001; 19:3210-3218<br />Lung Cancer]]></description>
<dc:creator>Karen Kelly, John Crowley, Paul A. Bunn Jr, Cary A. Presant, Patra K. Grevstad, Carol M. Moinpour, Scott D. Ramsey, Antoinette J. Wozniak, Geoffrey R. Weiss, Dennis F. Moore, Valerie K. Israel, Robert B. Livingston, David R. Gandara</dc:creator>
<dc:date>2001-07-01</dc:date>
<dc:title><![CDATA[Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non-Small-Cell Lung Cancer: A Southwest Oncology Group Trial]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/7/11/1748?rss=1&amp;ssource=mfc">
<title><![CDATA[Carboplatin dosage: prospective evaluation of a simple formula based on renal function]]></title>
<link>http://www.jco.org/cgi/content/short/7/11/1748?rss=1&amp;ssource=mfc</link>
<description><![CDATA[AH Calvert, DR Newell, LA Gumbrell, S O''Reilly, M Burnell, FE Boxall, ZH Siddik, IR Judson, ME Gore, E Wiltshaw<br />Nov  1, 1989; 7:1748-1756<br />ARTICLES]]></description>
<dc:creator>AH Calvert, DR Newell, LA Gumbrell, S O''Reilly, M Burnell, FE Boxall, ZH Siddik, IR Judson, ME Gore, E Wiltshaw</dc:creator>
<dc:date>1989-11-01</dc:date>
<dc:title><![CDATA[Carboplatin dosage: prospective evaluation of a simple formula based on renal function]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/17/5/1474?rss=1&amp;ssource=mfc">
<title><![CDATA[Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer]]></title>
<link>http://www.jco.org/cgi/content/short/17/5/1474?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Jennet M. Harvey, Gary M. Clark, C. Kent Osborne, D. Craig Allred<br />May  1, 1999; 17:1474-1474<br />Breast Cancer]]></description>
<dc:creator>Jennet M. Harvey, Gary M. Clark, C. Kent Osborne, D. Craig Allred</dc:creator>
<dc:date>1999-05-01</dc:date>
<dc:title><![CDATA[Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/19/13/3267?rss=1&amp;ssource=mfc">
<title><![CDATA[Phase I and Pharmacologic Study of OSI-774, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced Solid Malignancies]]></title>
<link>http://www.jco.org/cgi/content/short/19/13/3267?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Manuel Hidalgo, Lillian L. Siu, John Nemunaitis, Jinee Rizzo, Lisa A. Hammond, Chris Takimoto, S. Gail Eckhardt, Anthony Tolcher, Carolyn D. Britten, Louis Denis, Karen Ferrante, Daniel D. Von Hoff, Sandra Silberman, Eric K. Rowinsky<br />Jul  1, 2001; 19:3267-3279<br />Phase I and Clinical Pharmacology]]></description>
<dc:creator>Manuel Hidalgo, Lillian L. Siu, John Nemunaitis, Jinee Rizzo, Lisa A. Hammond, Chris Takimoto, S. Gail Eckhardt, Anthony Tolcher, Carolyn D. Britten, Louis Denis, Karen Ferrante, Daniel D. Von Hoff, Sandra Silberman, Eric K. Rowinsky</dc:creator>
<dc:date>2001-07-01</dc:date>
<dc:title><![CDATA[Phase I and Pharmacologic Study of OSI-774, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced Solid Malignancies]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/18/1/136?rss=1&amp;ssource=mfc">
<title><![CDATA[Phase III Multicenter Randomized Trial of Oxaliplatin Added to Chronomodulated Fluorouracil-Leucovorin as First-Line Treatment of Metastatic Colorectal Cancer]]></title>
<link>http://www.jco.org/cgi/content/short/18/1/136?rss=1&amp;ssource=mfc</link>
<description><![CDATA[S. Giacchetti, B. Perpoint, R. Zidani, N. Le Bail, R. Faggiuolo, C. Focan, P. Chollet, J. F. Llory, Y. Letourneau, B. Coudert, F. Bertheaut-Cvitkovic, D. Larregain-Fournier, A. Le Rol, S. Walter, R. Adam, J. L. Misset, F. Levi<br />Jan  5, 2000; 18:136-136<br />Gastrointestinal Cancer]]></description>
<dc:creator>S. Giacchetti, B. Perpoint, R. Zidani, N. Le Bail, R. Faggiuolo, C. Focan, P. Chollet, J. F. Llory, Y. Letourneau, B. Coudert, F. Bertheaut-Cvitkovic, D. Larregain-Fournier, A. Le Rol, S. Walter, R. Adam, J. L. Misset, F. Levi</dc:creator>
<dc:date>2000-01-05</dc:date>
<dc:title><![CDATA[Phase III Multicenter Randomized Trial of Oxaliplatin Added to Chronomodulated Fluorouracil-Leucovorin as First-Line Treatment of Metastatic Colorectal Cancer]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/19/18/3808?rss=1&amp;ssource=mfc">
<title><![CDATA[Letrozole Is More Effective Neoadjuvant Endocrine Therapy Than Tamoxifen for ErbB-1- and/or ErbB-2-Positive, Estrogen Receptor-Positive Primary Breast Cancer: Evidence From a Phase III Randomized Trial]]></title>
<link>http://www.jco.org/cgi/content/short/19/18/3808?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Matthew J. Ellis, Andrew Coop, Baljit Singh, Louis Mauriac, Antonio Llombert-Cussac, Fritz Janicke, William R. Miller, Dean B. Evans, Margaret Dugan, Carolyn Brady, Erhard Quebe-Fehling, Mieke Borgs<br />Sep 15, 2001; 19:3808-3816<br />RAPID PUBLICATIONS]]></description>
<dc:creator>Matthew J. Ellis, Andrew Coop, Baljit Singh, Louis Mauriac, Antonio Llombert-Cussac, Fritz Janicke, William R. Miller, Dean B. Evans, Margaret Dugan, Carolyn Brady, Erhard Quebe-Fehling, Mieke Borgs</dc:creator>
<dc:date>2001-09-15</dc:date>
<dc:title><![CDATA[Letrozole Is More Effective Neoadjuvant Endocrine Therapy Than Tamoxifen for ErbB-1- and/or ErbB-2-Positive, Estrogen Receptor-Positive Primary Breast Cancer: Evidence From a Phase III Randomized Trial]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/16/8/2659?rss=1&amp;ssource=mfc">
<title><![CDATA[Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment]]></title>
<link>http://www.jco.org/cgi/content/short/16/8/2659?rss=1&amp;ssource=mfc</link>
<description><![CDATA[MD Pegram, A Lipton, DF Hayes, BL Weber, JM Baselga, D Tripathy, D Baly, SA Baughman, T Twaddell, JA Glaspy, DJ Slamon<br />Aug  1, 1998; 16:2659-2671<br />ARTICLES]]></description>
<dc:creator>MD Pegram, A Lipton, DF Hayes, BL Weber, JM Baselga, D Tripathy, D Baly, SA Baughman, T Twaddell, JA Glaspy, DJ Slamon</dc:creator>
<dc:date>1998-08-01</dc:date>
<dc:title><![CDATA[Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/20/9/2240?rss=1&amp;ssource=mfc">
<title><![CDATA[ZD1839, a Selective Oral Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor, Is Well Tolerated and Active in Patients With Solid, Malignant Tumors: Results of a Phase I Trial]]></title>
<link>http://www.jco.org/cgi/content/short/20/9/2240?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Malcolm Ranson, Lisa A. Hammond, David Ferry, Mark Kris, Andrew Tullo, Philip I. Murray, Vince Miller, Steve Averbuch, Judy Ochs, Charles Morris, Andrea Feyereislova, Helen Swaisland, Eric K. Rowinsky<br />May  1, 2002; 20:2240-2250<br />Phase I and Clinical Pharmacology]]></description>
<dc:creator>Malcolm Ranson, Lisa A. Hammond, David Ferry, Mark Kris, Andrew Tullo, Philip I. Murray, Vince Miller, Steve Averbuch, Judy Ochs, Charles Morris, Andrea Feyereislova, Helen Swaisland, Eric K. Rowinsky</dc:creator>
<dc:date>2002-05-01</dc:date>
<dc:identifier>10.1200/JCO.2002.10.112</dc:identifier>
<dc:title><![CDATA[ZD1839, a Selective Oral Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor, Is Well Tolerated and Active in Patients With Solid, Malignant Tumors: Results of a Phase I Trial]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/23/10/2346?rss=1&amp;ssource=mfc">
<title><![CDATA[Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma]]></title>
<link>http://www.jco.org/cgi/content/short/23/10/2346?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Mark E. Dudley, John R. Wunderlich, James C. Yang, Richard M. Sherry, Suzanne L. Topalian, Nicholas P. Restifo, Richard E. Royal, Udai Kammula, Don E. White, Sharon A. Mavroukakis, Linda J. Rogers, Gerald J. Gracia, Stephanie A. Jones, David P. Mangiameli, Michelle M. Pelletier, Juan Gea-Banacloche, Michael R. Robinson, David M. Berman, Armando C. Filie, Andrea Abati, Steven A. Rosenberg<br />Apr  1, 2005; 23:2346-2357<br />Melanoma]]></description>
<dc:creator>Mark E. Dudley, John R. Wunderlich, James C. Yang, Richard M. Sherry, Suzanne L. Topalian, Nicholas P. Restifo, Richard E. Royal, Udai Kammula, Don E. White, Sharon A. Mavroukakis, Linda J. Rogers, Gerald J. Gracia, Stephanie A. Jones, David P. Mangiameli, Michelle M. Pelletier, Juan Gea-Banacloche, Michael R. Robinson, David M. Berman, Armando C. Filie, Andrea Abati, Steven A. Rosenberg</dc:creator>
<dc:date>2005-04-01</dc:date>
<dc:identifier>10.1200/JCO.2005.00.240</dc:identifier>
<dc:title><![CDATA[Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/22/11/2184?rss=1&amp;ssource=mfc">
<title><![CDATA[Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer]]></title>
<link>http://www.jco.org/cgi/content/short/22/11/2184?rss=1&amp;ssource=mfc</link>
<description><![CDATA[David H. Johnson, Louis Fehrenbacher, William F. Novotny, Roy S. Herbst, John J. Nemunaitis, David M. Jablons, Corey J. Langer, Russell F. DeVore III, Jacques Gaudreault, Lisa A. Damico, Eric Holmgren, Fairooz Kabbinavar<br />Jun  1, 2004; 22:2184-2191<br />Lung Cancer]]></description>
<dc:creator>David H. Johnson, Louis Fehrenbacher, William F. Novotny, Roy S. Herbst, John J. Nemunaitis, David M. Jablons, Corey J. Langer, Russell F. DeVore III, Jacques Gaudreault, Lisa A. Damico, Eric Holmgren, Fairooz Kabbinavar</dc:creator>
<dc:date>2004-06-01</dc:date>
<dc:title><![CDATA[Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/17/11/3461?rss=1&amp;ssource=mfc">
<title><![CDATA[Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working Group]]></title>
<link>http://www.jco.org/cgi/content/short/17/11/3461?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Glenn J. Bubley, Michael Carducci, William Dahut, Nancy Dawson, Danai Daliani, Mario Eisenberger, William D. Figg, Boris Freidlin, Susan Halabi, Gary Hudes, Maha Hussain, Richard Kaplan, Charles Myers, William Oh, Daniel P. Petrylak, Eddie Reed, Bruce Roth, Oliver Sartor, Howard Scher, Jonathan Simons, Vickie Sinibaldi, Eric J. Small, Matthew R. Smith, Donald L. Trump, Robin Vollmer, George Wilding<br />Nov  1, 1999; 17:3461-3467<br />Genitourinary Cancer]]></description>
<dc:creator>Glenn J. Bubley, Michael Carducci, William Dahut, Nancy Dawson, Danai Daliani, Mario Eisenberger, William D. Figg, Boris Freidlin, Susan Halabi, Gary Hudes, Maha Hussain, Richard Kaplan, Charles Myers, William Oh, Daniel P. Petrylak, Eddie Reed, Bruce Roth, Oliver Sartor, Howard Scher, Jonathan Simons, Vickie Sinibaldi, Eric J. Small, Matthew R. Smith, Donald L. Trump, Robin Vollmer, George Wilding</dc:creator>
<dc:date>1999-11-01</dc:date>
<dc:title><![CDATA[Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working Group]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/21/14/2787?rss=1&amp;ssource=mfc">
<title><![CDATA[Status of Epidermal Growth Factor Receptor Antagonists in the Biology and Treatment of Cancer]]></title>
<link>http://www.jco.org/cgi/content/short/21/14/2787?rss=1&amp;ssource=mfc</link>
<description><![CDATA[John Mendelsohn, Jose Baselga<br />Jul 15, 2003; 21:2787-2799<br />BIOLOGY OF NEOPLASIA]]></description>
<dc:creator>John Mendelsohn, Jose Baselga</dc:creator>
<dc:date>2003-07-15</dc:date>
<dc:title><![CDATA[Status of Epidermal Growth Factor Receptor Antagonists in the Biology and Treatment of Cancer]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/20/21/4292?rss=1&amp;ssource=mfc">
<title><![CDATA[Phase I Safety, Pharmacokinetic, and Pharmacodynamic Trial of ZD1839, a Selective Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Five Selected Solid Tumor Types]]></title>
<link>http://www.jco.org/cgi/content/short/20/21/4292?rss=1&amp;ssource=mfc</link>
<description><![CDATA[J. Baselga, D. Rischin, M. Ranson, H. Calvert, E. Raymond, D.G. Kieback, S.B. Kaye, L. Gianni, A. Harris, T. Bjork, S.D. Averbuch, A. Feyereislova, H. Swaisland, F. Rojo, J. Albanell<br />Nov  1, 2002; 20:4292-4302<br />Phase I and Clinical Pharmacology]]></description>
<dc:creator>J. Baselga, D. Rischin, M. Ranson, H. Calvert, E. Raymond, D.G. Kieback, S.B. Kaye, L. Gianni, A. Harris, T. Bjork, S.D. Averbuch, A. Feyereislova, H. Swaisland, F. Rojo, J. Albanell</dc:creator>
<dc:date>2002-11-01</dc:date>
<dc:title><![CDATA[Phase I Safety, Pharmacokinetic, and Pharmacodynamic Trial of ZD1839, a Selective Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Five Selected Solid Tumor Types]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/19/11/2865?rss=1&amp;ssource=mfc">
<title><![CDATA[Effects of Epoetin Alfa on Hematologic Parameters and Quality of Life in Cancer Patients Receiving Nonplatinum Chemotherapy: Results of a Randomized, Double-Blind, Placebo-Controlled Trial]]></title>
<link>http://www.jco.org/cgi/content/short/19/11/2865?rss=1&amp;ssource=mfc</link>
<description><![CDATA[T. J. Littlewood, E. Bajetta, J. W.R. Nortier, E. Vercammen, B. Rapoport<br />Jun  1, 2001; 19:2865-2874<br />Supportive Care and Quality of Life]]></description>
<dc:creator>T. J. Littlewood, E. Bajetta, J. W.R. Nortier, E. Vercammen, B. Rapoport</dc:creator>
<dc:date>2001-06-01</dc:date>
<dc:title><![CDATA[Effects of Epoetin Alfa on Hematologic Parameters and Quality of Life in Cancer Patients Receiving Nonplatinum Chemotherapy: Results of a Randomized, Double-Blind, Placebo-Controlled Trial]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/15/2/433?rss=1&amp;ssource=mfc">
<title><![CDATA[Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation]]></title>
<link>http://www.jco.org/cgi/content/short/15/2/433?rss=1&amp;ssource=mfc</link>
<description><![CDATA[RH Collins Jr, O Shpilberg, WR Drobyski, DL Porter, S Giralt, R Champlin, SA Goodman, SN Wolff, W Hu, C Verfaillie, A List, W Dalton, N Ognoskie, A Chetrit, JH Antin, J Nemunaitis<br />Feb  1, 1997; 15:433-444<br />ARTICLES]]></description>
<dc:creator>RH Collins Jr, O Shpilberg, WR Drobyski, DL Porter, S Giralt, R Champlin, SA Goodman, SN Wolff, W Hu, C Verfaillie, A List, W Dalton, N Ognoskie, A Chetrit, JH Antin, J Nemunaitis</dc:creator>
<dc:date>1997-02-01</dc:date>
<dc:title><![CDATA[Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/22/16/3238?rss=1&amp;ssource=mfc">
<title><![CDATA[Determinants of Tumor Response and Survival With Erlotinib in Patients With Non--Small-Cell Lung Cancer]]></title>
<link>http://www.jco.org/cgi/content/short/22/16/3238?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Roman Perez-Soler, Abraham Chachoua, Lisa A. Hammond, Eric K. Rowinsky, Mark Huberman, Daniel Karp, James Rigas, Gary M. Clark, Pedro Santabarbara, Philip Bonomi<br />Aug 15, 2004; 22:3238-3247<br />Lung Cancer]]></description>
<dc:creator>Roman Perez-Soler, Abraham Chachoua, Lisa A. Hammond, Eric K. Rowinsky, Mark Huberman, Daniel Karp, James Rigas, Gary M. Clark, Pedro Santabarbara, Philip Bonomi</dc:creator>
<dc:date>2004-08-15</dc:date>
<dc:identifier>10.1200/JCO.2004.11.057</dc:identifier>
<dc:title><![CDATA[Determinants of Tumor Response and Survival With Erlotinib in Patients With Non--Small-Cell Lung Cancer]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/8/5/813?rss=1&amp;ssource=mfc">
<title><![CDATA[Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia]]></title>
<link>http://www.jco.org/cgi/content/short/8/5/813?rss=1&amp;ssource=mfc</link>
<description><![CDATA[BD Cheson, PA Cassileth, DR Head, CA Schiffer, JM Bennett, CD Bloomfield, R Brunning, RP Gale, MR Grever, MJ Keating<br />May  1, 1990; 8:813-819<br />ARTICLES]]></description>
<dc:creator>BD Cheson, PA Cassileth, DR Head, CA Schiffer, JM Bennett, CD Bloomfield, R Brunning, RP Gale, MR Grever, MJ Keating</dc:creator>
<dc:date>1990-05-01</dc:date>
<dc:title><![CDATA[Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/23/5/1011?rss=1&amp;ssource=mfc">
<title><![CDATA[Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis]]></title>
<link>http://www.jco.org/cgi/content/short/23/5/1011?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Daniel J. Hicklin, Lee M. Ellis<br />Feb 10, 2005; 23:1011-1027<br />]]></description>
<dc:creator>Daniel J. Hicklin, Lee M. Ellis</dc:creator>
<dc:date>2005-02-10</dc:date>
<dc:title><![CDATA[Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/23/25/5892?rss=1&amp;ssource=mfc">
<title><![CDATA[TRIBUTE: A Phase III Trial of Erlotinib Hydrochloride (OSI-774) Combined With Carboplatin and Paclitaxel Chemotherapy in Advanced Non-Small-Cell Lung Cancer]]></title>
<link>http://www.jco.org/cgi/content/short/23/25/5892?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Roy S. Herbst, Diane Prager, Robert Hermann, Lou Fehrenbacher, Bruce E. Johnson, Alan Sandler, Mark G. Kris, Hai T. Tran, Pam Klein, Xin Li, David Ramies, David H. Johnson, Vincent A. Miller<br />Sep  1, 2005; 23:5892-5899<br />Lung Cancer]]></description>
<dc:creator>Roy S. Herbst, Diane Prager, Robert Hermann, Lou Fehrenbacher, Bruce E. Johnson, Alan Sandler, Mark G. Kris, Hai T. Tran, Pam Klein, Xin Li, David Ramies, David H. Johnson, Vincent A. Miller</dc:creator>
<dc:date>2005-09-01</dc:date>
<dc:title><![CDATA[TRIBUTE: A Phase III Trial of Erlotinib Hydrochloride (OSI-774) Combined With Carboplatin and Paclitaxel Chemotherapy in Advanced Non-Small-Cell Lung Cancer]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/18/12/2354?rss=1&amp;ssource=mfc">
<title><![CDATA[Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non-Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy Regimens]]></title>
<link>http://www.jco.org/cgi/content/short/18/12/2354?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Frank V. Fossella, Russell DeVore, Ronald N. Kerr, Jeffrey Crawford, Ronald R. Natale, Frank Dunphy, Leonard Kalman, Vincent Miller, Jin Soo Lee, Melvin Moore, David Gandara, Daniel Karp, Everett Vokes, Mark Kris, Yong Kim, Francis Gamza, Luz Hammershaimb<br />Jun 12, 2000; 18:2354-2362<br />Lung Cancer]]></description>
<dc:creator>Frank V. Fossella, Russell DeVore, Ronald N. Kerr, Jeffrey Crawford, Ronald R. Natale, Frank Dunphy, Leonard Kalman, Vincent Miller, Jin Soo Lee, Melvin Moore, David Gandara, Daniel Karp, Everett Vokes, Mark Kris, Yong Kim, Francis Gamza, Luz Hammershaimb</dc:creator>
<dc:date>2000-06-12</dc:date>
<dc:title><![CDATA[Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non-Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy Regimens]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/10/6/896?rss=1&amp;ssource=mfc">
<title><![CDATA[Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project]]></title>
<link>http://www.jco.org/cgi/content/short/10/6/896?rss=1&amp;ssource=mfc</link>
<description><![CDATA[<br />Jun  1, 1992; 10:896-903<br />ARTICLES]]></description>
<dc:date>1992-06-01</dc:date>
<dc:title><![CDATA[Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

<item rdf:about="http://www.jco.org/cgi/content/short/15/2/594?rss=1&amp;ssource=mfc">
<title><![CDATA[International Germ Cell Consensus Classification: a prognostic factor- based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group]]></title>
<link>http://www.jco.org/cgi/content/short/15/2/594?rss=1&amp;ssource=mfc</link>
<description><![CDATA[<br />Feb  1, 1997; 15:594-603<br />ARTICLES]]></description>
<dc:date>1997-02-01</dc:date>
<dc:title><![CDATA[International Germ Cell Consensus Classification: a prognostic factor- based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group]]></dc:title>
<dc:publisher>American Society of Clinical Oncology</dc:publisher>
</item>

</rdf:RDF>